SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Ampio Pharmaceuticals, Inc. (AMPE) .
本页证实的标准:
- VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。
SharesGrow 综合评分: 47/100 其中 2/7 项标准通过。
SharesGrow 7-Criteria Score
✓
健康
100/100
Debt-to-Equity & liquidity
→ Health
估值概览 — AMPE
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$-10.66
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS(稀释) |
营收 |
净利润 |
净利润率 |
| 2014 |
$-227.72 |
$76.79K |
$-38.13M |
-49650.3% |
| 2015 |
$-184.70 |
$1.16M |
$-32.01M |
-2754.7% |
| 2016 |
$-106.91 |
$0.00 |
$-19.16M |
- |
| 2017 |
$-238.41 |
$0.00 |
$-51.89M |
- |
| 2018 |
$91.90 |
$0.00 |
$33.99M |
- |
| 2019 |
$-18.32 |
$0.00 |
$-13.63M |
- |
| 2020 |
$-27.00 |
$0.00 |
$-15.89M |
- |
| 2021 |
$-18.59 |
$0.00 |
$-17.08M |
- |
| 2022 |
$-11.24 |
$0.00 |
$-16.34M |
- |
| 2023 |
$-10.66 |
$0.00 |
$-8.63M |
- |